G

Genelux Corp
D

GNLX

2.78200
USD
0.10
(3.81%)
مغلق
حجم التداول
0
الربح لكل سهم
-1
العائد الربحي
-
P/E
-3
حجم السوق
124,406,695
أصول ذات صلة المقالات

العنوان: Genelux Corp

القطاع: Healthcare
الصناعة: Biotechnology
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.